欧 文
  1. Thota A, Karajgikar M, Duan W, Gabril MY, Chan FL, Wong YC, Sakai H, Chin JL, Moussa M, Xuan JW: Mouse PSP94 expression is prostate tissue-specific as demonstrated by a comparison of multiple antibodies against recombinant proteins. J Cell Biochem 88(5):999-1011, 2003
  2. Mori K, Noguchi M, Matsuo M, Nomata K, Nakamura T, Kanetake H: Natural course of voiding function in patients with human T-cell lymphotrophic virus type 1-associated myelopathy. J Neurol Sci, 217:3‐6,2004
  3. Kanda S, Miyata Y, Kanetake H: Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1. J Biol Chem, 279(6):4007‐4016,2004
  4. Miyata Y, Kanda S, Nomata K, Hayashida Y, Kanetake H: Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. Urology, 63(3):602‐608,2004
  5. Lee M-S, Igawa T, Chen S-J, Bemmel DV, Lin JS, F-F.Lin, Johansson SL, Christman JK, Lin M-F: p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. Int J Cancer, 108:672‐678,2004
  6. Lee MS, .Igawa, Lin M-F: Tyrosine-317 of p52Shc mediates androgen-stimulated proliferation signals in human prostate cancer cells. Oncogene, 23:3048‐3058,2004
  7. Akaza H, Yamaguchi A, Matsuda T, Igawa M, Kumon H, Soeda A, Arai Y, Usami M, Naito S, Kanetake H, Ohashi Y:  Superior anti-tumor effecacy of bicalutamide 80mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer; Interim results of randomized study in Japanese patients. Jpn J Clin Oncol, 34(1):20‐28,2004
  8. Miyata Y, Sakai H, Kanda S, Igawa T, Hayashi T, Kanetake H: Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: Correlation with histopathologic effects and biochemical recurreence. Urology, 63(6):1184‐1190,2004
  9. Hisamatsu H, Sakai H, Tsuda S, Shigematsu K, Kanetake H: Combined adrenal adenoma and myelolipoma in a patient with Cushingユs syndrome: Case report and review of the literature. Int J Urol, 11:416‐418,2004
  10. Mori K, Koga S, Noguchi M, Kanetake H, Suda H, Yamashita S: Spontaneous peripelvic extravasation of urine due to an inflammatory aneurysm of the abdominal aorta. Int J Urol, 11:419‐420,2004
  11. Ohba K, Matsuo M, Noguchi,M Nishikido M, Koga S, Kanetake H, Nazneen A, Liu D, Lazzaque MS, Taguchi T: Clinicopathological study of vesicoureteral reflux (VUR)-associated pyelonephritis in renal transplantation. Clin Transplant, 18(Suppl.11):34‐38,2004
  12. Nishikido M, Noguchi M, Koga S, Kanetake H, Harada T, Taguchi T, Watanabe J, Matsuya F, Hayashi M: Different clinicopathological courses of two recipients of kidneys retrieved from the same non-heart beating donor. Clin Transplant, 18(Suppl.11):54‐60,2004
  13. Hayashida Y, Nomata K, Noguchi M, Eguchi J, Koga S, Yamashita S, Hayashi M, Kanetake H: Long-term effects of bacille calmette-guerin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract. Urology, 63(6):1084‐1088,2004
  14. Kondoh T, Eguchi J, Hamasaki Y, Doi T, Kinoshita E, Matsumoto T, Abe K, Ohtani Y, Moriuchi H: Hearing impairment, undescended testis, circumferential skin creases, and mental handicap (HITCH) syndrome: A case report. Am J Med Genet, 125A:290‐292,2004
  15. Miyata Y, Shindo K, Matsuya F, Noguchi M, Nishikido M, Koga S, Kanetake H: Erectile dysfunction in hemodialysis patients with diabetes mellitus: Association with age and hemoglobin A1c levels. Int J Urol, 11(7):530‐534,2004
  16. Kanda S, Miyata Y, Kanetake H: Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal, 16:1273‐1281,2004
  17. Nishikido M, Noguchi M, Koga S, Kanetake H, Matsuya F, Hayashi M, Hori T, Shindo K: Kidney transplantation from non-heart-beating donors: Analysis of organ procurement and outcome. Transplant P, 36(7):1888‐1890,2004
  18. Takehara K, Nomata K, Eguchi J, Hisamatsu H, Maruta S, Hayashi T, Koga S, Kanetake H:Mucinous adenocarcinoma of the renal pelvis associated with transitional cell carcinoma in the renal pelvis and the bladder. Int J Urol, 11(11):1016‐1018,2004
  19. Noguchi M, Hirashima S, Eishi K, Takahashi H, Hazama S, Takai H, Koga S: Surgical treatment of abdominal aortic aneurysm associated with horseshoe kidney and coagulopathy. J Cardiovasc Surg, 45(5):505‐509,2004
  20. Takahashi H, Nomata K, Mor Ki, Matsuo M, Miyaguchi T, Noguchi M, Kanetake H: The preventive effect of green tea on the gap junction intercellular communication in renal epithelial cells treated with a renal carcinogen. Anticancer Res, 24:3757‐3762,2004
  21. Aoki D, Yamamoto-Fukuda T, Hishikawa Y, Nakamura M, Sakai H, Kanetake H, Koji T: Coexpression of keratinocyte growth factor and its receptor in normal and prostate cancer tissues: Possible formation of autonomous andromedin loop. Acta Histochem Cytoc, 37(6):379‐389,2004

  1. Koga S: Filarial chyluria: Long-term experience of a University Hospital in India. Int J Urol, 11(4):199,2004
  2. Ohba K, Nishikido M, Koga S, Kanetake H, Taguchi T: Interstitial expression of heat shock protein 47 associated with capillary deposition of complement split product C4d in chronic allograft nephrology. Clin Invest Med, 27(4):155D,2004
  3. Inuzuka S, Koga S, Nishikido M, Ohba K, Miyata Y, Kanetake H: Donor-specific blood transfusion prolongs cardiac allograft survival in rats: The role of nitric oxide, prostaglandin E2 apoptosis. Clin Invest Med, 27(4):150D,2004
  4. Igawa T, Kusaba Y, Iwasaki S, Hara T, Shono T, Sakai H, Kanetake H: A randomized-clinical trial of chemo-endocrine therapy with cisplatin and pirarubicin vs endocrine therapy alone in newly diagnosed patients with advanced prostate cancer. BJU Int, 94(suppl.2):51,2004
  5. Kanetake H, Akaza H, Usami M, Ohashi Y, Japan Flutamide Study Cooperative: A phase Ⅲ randomized trial of low-dose flutamide combined with luteinizing hormone-releasing hormone agonist (LHRHa) vs HLRHa monotherapy for advanced prostate cancer. BJU Int, 94(Suppl.2):58‐59,2004
  6. Nomata K, Hayashida Y, Noguchi M, Eguchi J, Yamashita S, Hayashi M, Kanetake H: Long-term effects of bacillus Calmette-Guerin perfusion therapy for treatment of transitional cell carcinoma in situ of the upper urinary tract. BJU Int, 94(Suppl.2):107‐108,2004
  7. Matsuo Y, Aoki D, Eguchi J, Nomata K, Hayashi T, Hishikawa Y, Koji T, Kanetake H: Expression of connexin 43 in human infertile testis. BJU Int, 94(Suppl.2):189,2004
  8. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S: Sustained prophylactic effect of intravesical bacillus Calmette-Guerin for superficial bladder cancer: Smoothed hazards analysis in randomized prospective study. BJU Int, 94(Suppl.2):245,2004
  9. Tanaka M, Naito S, Matsumoto T, Oshima K, Matsuoka K, Masaki Z, Kanetake H, Ueda S, Nomura Y, Osada Y: Survey on the trends in performing a laparoscopic adrenalectomy in the Kyushu district, Japan. BJU Int, 94(Suppl.2):292,2004

  1. Inuzuka S, Koga S, Nishikido M, Ohba K, Miyata Y, Kanetake H: Donor-specific blood transfusion prolongs cardiac allograft survival in rats: The role of nitric oxide, prostaglandin E2 and apoptosis. Immunology、2004 (International Proceedings), 95‐97,2004
邦 文
  1. 溝口協子、濱崎洋一郎、片山一朗、井川 掌:酢酸リュープロレリン(3ヵ月持続徐放性製剤)により生じた肉芽腫の1例―1ヵ月製剤から3ヵ月製剤へ転換すると、著明に増悪した例―.日皮会誌、114(2):163‐167,2004
  2. 酒井英樹、井川 掌、金武 洋、林 幹男、岩崎昌太郎、斉藤 泰、草場泰之、進藤和彦、計屋紘信、原 種利:泌尿器癌治療とQOL前立腺癌内分泌療法におけるQOL に関する縦断的研究.西日本泌尿器科、66(4):272‐278,2004
  3. 三島陽子、原田孝司、宮崎正信、錦戸雅春、古賀成彦、金武 洋、吉田真一郎、朝長万左男、河野 茂:クリオフィルトレーションでネフローゼ症候群が改善した悪性リンパ腫に合併したC型肝炎ウイルス関連混合型クリオグロブリン血症の1例.透析会誌、37(6):1431‐1435,2004
  4. 錦戸雅春:心停止下献腎移植において、ミコフェノール酸モフェチルとバシリキシマブ、タクロリムスの併用により急性拒絶反応が抑制された1例.Renal Transplantation、5(3):14‐15,2004
  5. 宮田康好、酒井英樹、井川 掌、神田 滋、金武 洋:免疫組織化学的検討から見たneoadjuvant hormonal therapyの期間についての検討.泌尿器外科、17(8):843‐846,2004
  6. 井川 掌、宮田康好、酒井英樹、金武 洋:根治的前立腺全摘術後のPSA再発症例の検討―内分泌療法開始時期について―.泌尿器外科、17(8):887‐891,2004
  7. 九州泌尿器科共同研究会、田中正利、内藤誠二、古賀寛史、松本哲朗、高橋康一、有吉朝美、大島一寛、辻 祐治、平塚義治、野田進士、松岡 啓、宮原 茂、真崎善二郎、魚住二郎、金武 洋、古賀成彦、酒井英樹、上田昭一、吉田正貴、野村芳雄、三股浩光、長田幸夫、蓮井良浩、中川昌之、川原元司、小川由英、秦野 直:九州地区における腹腔鏡下副腎摘除術の動向に関する臨床的検討―第13回九州泌尿器科共同研究―.西日本泌尿器科、66(12):733‐745,2004
  8. 田中正利、江藤稔久、内藤誠二、村谷哲郎、松本哲朗、金武 洋、木谷公亮、上田昭一、川原元司、 中川昌之、小川由英、中山 宏、小松 潔、山口秋人、占部治邦、天本太平、湯下芳明、徳永 毅、南 祐三、鈴 博司、計屋紘信、平山英雄、野尻明弘、川野四郎、片平可也、生駒道明、川原和也、今村厚志、加治木邦彦、中目康彦、島田 剛、後藤俊弘、下稲葉耕生、嶺井定一、佐々本操、大城吉則、富山裕一、名城文雄、我喜屋宗久、小林寅_:九州地域における薬剤耐性淋菌の分離状況に関する研究.臨牀と研究、81(12):2030‐2036,2004

  1. 野口 満:特別企画―ED治療にとりくむ医療機関―患者さんの不安に配慮した診療―大学病院編 泌尿器科専門医からの対応.日本醫事新報、4197:C1‐3,2004

  1. 上村博司、酒井英樹:内分泌療法の新戦略―その適応基準と施行時期―(第19回前立腺シンポジウム記録)内分泌療法と化学療法の併用.泌尿器外科、17(8):914‐916,2004
  2. 酒井英樹:6章―医学部附属病院公開講座「生き生き健康ライフ講座V」前立腺がんの早期診断と治療の最前線(pp305‐308),長崎大学生涯学習叢書3大学公開講座と評価.編集:長崎大学生涯教育研究センター運営委員会.長崎大学(長崎)338p,2004.(3月)
  3. 古賀寛史、酒井英樹:前立腺癌―最新の診断と治療法―BSラジオNIKKEI医学特別番組<明日の治療指針>扶桑薬品工業

  1. 古賀成彦、宮崎正信:Ⅶ.泌尿器科検査と処置―腎生検(pp398‐401).泌尿器科周術期管理のすべて.編集:荒井陽一、松田公志.(株)メジカルビュー社(東京)432p,2004.(4月)

  1. 酒井英樹:診療茶話:前立腺癌治療の移り変わり.長崎県医師会報、699:75‐76,2004
  2. 野口 満:生涯教育シリーズ:日常よく診る小児泌尿器科疾患.長崎市医師会報、38(7):16‐19,2004